期刊文献+

Cad11高和低表达肾癌细胞分选与Cad11对肾癌细胞迁移作用的影响 被引量:2

Sorting of Cad11+ and Cad11- cells from renal carcinoma cells and its effect on migration of renal carcinoma cells
原文传递
导出
摘要 目的分选Ⅱ型成骨细胞型钙黏附蛋白(cadherin-11,Cad11)高和低表达的肾癌细胞786-O细胞群,并证实Cad11在肾癌细胞786-O中的迁移作用。方法将质粒pBMN-Ⅰ-GFP-Cad11转染于Phoenix细胞进行包装,之后感染786-O细胞,流式细胞仪分选后扩大培养建立786-LG细胞。将786-LG细胞经Cad11抗体2C7孵育后用BSA封闭,洗涤后加入标记APC的二抗,同时以786-LG细胞(未经任何处理)和786-LG细胞(只加入标记APC的二抗处理)作为阴性对照确定分选门,绿色荧光通道和红色荧光通道进行双参数分析,流式细胞仪分选技术筛选Cad11高和低表达的786-O肾癌细胞群,蛋白质印迹法检测分选细胞Cad11的表达。786-Cad11+和786-Cad11-细胞血清饥饿24h后接种于内室(细胞数为1×104),每组设3个复孔,Transwell细胞迁移实验和细胞结晶紫染色计数穿过小室的细胞数目,以穿过膜的细胞数目评估Cad11对其肾癌细胞786-O的迁移作用。结果成功构建786-LG细胞。流式细胞仪检测结果显示,786-LG细胞中Cad11阳性细胞亚群占细胞总数的75.98%。Cad11细胞群分选后,GFP+/APC+双阳性细胞和GFP+/APC-单阳性细胞分别占细胞总数的28.0%和20.1%。蛋白质印迹法检测结果表明,Cad11相对表达量786-LG细胞为0.25±0.02,786-Cad11+细胞为0.60±0.03,786-Cad11-细胞为0.10±0.01,差异有统计学意义,F=132.32,P<0.001。与786-LG细胞相比,两个细胞亚群786-Cad11+和786-Cad11-中Cad11蛋白的表达量均有明显变化,前者蛋白表达量升高至2.41倍(P=0.007),后者蛋白表达量降低至0.41倍(P=0.004),差异均有统计学意义。Transwell迁移实验结果表明,786-LG细胞迁移数目为114.33±4.09,786-Cad11+细胞迁移数目为139.00±5.19,786-Cad11-细胞迁移数目为77.67±3.71,差异有统计学意义,F=49.65,P=0.000 2。结论成功建立了高和低表达Cad11的786-O细胞模型,并证实Cad11的表达与肾癌细胞的迁移密切相关。 OBJECTIVE To sort Cadll+ and Cadll-- cells from renal carcinoma 786-O cell line and show the effect of Cadll on migration of renal carcinoma 786-O cell. METHODS The plasmid pBMN- I GFP-Cadll was transfect- ed into the Phoenix cells,and the virus-producing cell supernatant was harvested to infect 786-O cells. The flow cytometry was used to detect and isolate the infected 786-O cells and the 786-LG cells were established after amplification culture. The 786-LG cells were incubated with anti-Cadll antibody 2C7 and blocked with BSA. After washing several times, cells were incubated with APC conjugated secondary antibody. In order to set up sort gate, 786-LG cells (without any treat- ment) and 786-LG cells (incubated with APC conjugated secondary antibody) were used as negative controls. Based on the double parameter analysis of green and red fluorescence channels,Cadl 1 + and Cadl 1- cells were sorted by the flow cy- tometry. The Cadll expression of sorted cells was detected by western blotting at protein level. 786-Cadll + and 786-Cad11+cells were serum starved for 24 h and seeded into transwell culture insert (each containing 1 × 104 cells). There were 3 holes per group. Transwell migration was assayed and crystal violet staining was used to count cells those had passed the transwell membrane. RESULTS The 786-LG cells were established successfully. The flow cytometry showed that Cadll expression was positive in 786-LG cells (75. 98%). After the fluorescence activating cell sorter, GFP+/APC+ cells(28.0%) and GFP+/APC+ cells (20.1%)were sorted successfully. Western blot showed that the relative expression of Cadll was obviously increased in 786-Cad11+ cells (0.60±0.03) and decreased in 786-Cadll- cells (0.10±0.01) compared with 786-LG cells (0.25±0.02) ,F=132.32,P〈0. 001. As a result,the rates of protein ex- pression were increased to 2.41 in 786-Cadll + cells (P=0. 007) and decreased to 0. 41 in 786-Cadll- cells (P= 0. 004). Transwell migration assay showed that the number of migrated cells in 786 LG were 114.33 ± 4.09,786-Cadll + cell group were 139.00± 5. 19, and 786-Cadll- cell group were 77. 67 ±3.71, differences were statistically significant (F=49.65,P=0.000 2).CONCLUSION 786-Cad11-- and 786-Cad11+ceils have been established and the expression of Cadll is closely related to the migration of renal carcinoma cell.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第6期427-431,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81101596)
关键词 Ⅱ型成骨细胞型钙黏附蛋白 分选 肾癌细胞 迁移 cadherin-11 sorting renal carcinoma cell migration
  • 相关文献

参考文献19

  • 1Bianchi M, Sun M, Jeldres C, et al. Distribution of metastatic sites in renal cell carcinoma a population-based analysis[J]. Ann Oneol,2012,23(4) :973-980.
  • 2Woodward E, Jagdev S, McParland L, et al. Skeletal complica- tions and survival in renal cancer patients with bone metastases [J]. Bone,2011,48(1) :160-166.
  • 3Wood SL,Brown JE. Skeletal metastasis in renal cell carcinoma: current and {uture management options[J]. Cancer Treat Rev, 2012,38(4) :284 291.
  • 4Pishvaian MJ,Feltes CM,Thompson P,et al. Cadherin 11 is ex- pressed in invasive breast cancer cell lines [J]. Cancer Res, 1999, 59(4) :947 952.
  • 5Chu K,Cheng CJ,Ye X,et al. Cadherin 11 promotes the metasta- sis of prostate cancer cells to bone[J]. Mol Cancer Res, 2008,6 (8) : 1259-1267.
  • 6Monahan TS, Andersen ND, Panossian H, et al. A novel function for cadherin ll/osteoblast-eadherin in vascular smooth muscle cells:modulation of cell migration and proliferation[J]. J Vasc Surg,2007,45(3) :581-589.
  • 7Lee YC, Bilen MA, Yu G, et al. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis[J]. Mol Cancer Res,2013,11(11) :1401-1411.
  • 8Lein M,Jung K, Laube C, et al. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma[J]. Int J Cancer, 2000,85 (6) : 801-804.
  • 9Zhao FL,Guo W. Expression of stromal derived factor-1 (SDF-1) and chemokine receptor (CXCR4) in bone metastasis of renal carcinoma J]. Mol Biol Rep,2011,38(2) :1039-1045.
  • 10Mikami S,Oya M,Shimoda M,et al. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prog- nosis[J]. Clin Cancer Res, 2008,14 (19) : 6055-6061.

二级参考文献55

  • 1Reya T,Morrison SJ,Clarke MF,et al. Stem cells,cancer, and cancer stem cells [J]. Nature,200,414 (6859) : 105- 111.
  • 2Martinez-Climent JA, Andreu EJ, Prosper F. Somatic stem Cells and the origin of cancer [J]. Clin Transl Oncol,2006,8:647-663.
  • 3Goodell MA, Brose K, Paradis G, et al. Isolation and func- tional properties of murine hematopoietic stem cells that are replicating in vivo [J]. J Exp Med,1996,183 (4): 1797-1806.
  • 4Challen GA,Little MH. A side order of stem cells:the SP phenotype [ J ]. Stem Cells, 2006,24 ( 1 ) : 3-12.
  • 5Croker AK,Allan AL. Cancer stem cells:implications for the progression and treatment of metastatic disease [J]. J Cell Mol Med, 2008, ! 2 (2) : 374-390.
  • 6Hadnagy A,Gaboury L,Beaulieu R,et al. SP analysis may be used to identify cancer stem cell populations [J]. Exp Cell Res,2006,312(19) :3701-3710.
  • 7Chiba T,Kita K,Zheng YW,et al. Side population puri- fied from hepatocellular carcinoma ceils harbors cancer stem cell-like properties [J]. Hepatology,2006,44 (1) : 240-251.
  • 8Yao J,Cai HH,Wei JS,et al. Side population in the pan- creatic cancer cell lines SW1990 and CFPAC-1 is en- riched with cancer stem-li ke cells [J]. Oncol Rep, 2010,23(5) : 1375-1382.
  • 9She JJ,Zhang PG, Wang ZM,et al. Identification of side population ceils from bladder cancer cells by DyeCycle Violet staining [ J ]. Cancer Biol Ther, 2008,7 (10) : 1663 - 1668.
  • 10Haraguchi N, Utsunomiya T,Inoue H, et al. Characteriza- tion of a side population of cancer cells from human gas- trointestinal system [ J ]. Stem Cells, 2006,24 (3) : 506- 513.

共引文献9

同被引文献26

  • 1Remon J, Lianes P, Martinez S. Brain metastases from renal cell carcinoma. Should we change the current standard? [J]. Cancer Treat Rev,2012,38(4) : 249-257.
  • 2Joly MO,Attignon V,Saurin ]C,et al. Somatic MMR gene mu- tations as a cause for MSI-H sebaceous neoplasms in Muir-Torre syndrome-like patients[J]. Hum Mutat, 2015,36 (3) : 292-295.
  • 3Wu SY,Pan SL, XIAO ZY, et al. NPRL-Z-I,as a new topoi somerase lI poison,induces cell apoptosis and ROS generation in human renal carcinoma cells[J/CD]. PLoS One, 2014,9 (11) : e112220.
  • 4Poillet-perez L,Despouy G, Delage-mourroux R, et al. Interplay between ROS and autophagy in cancer cells, from tumor initia-tion to cancer therapy[J].Redox Biol, 2015,4 : 184-192.
  • 5Xu J, Guo Z, Bai Y, et al. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with the kid- ney survival time in chronic kidney disease patients [J]. Ren Fail,2015,37(1) : 108-112.
  • 6Bai Y,Guo Z,Xu J,et al. Association of sequence polymorphism in the mitochondrial D-loop with chronic kidney disease[J]. Ren Fail,2014,36(5) : 781-784.
  • 7Xu J,Guo Z,Zhang J,et al. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of renal cell carcinoma[J]. Sci Rep, 2013,3 : 2408.
  • 8Hibi K, Nakayama H, Yamazaki T, et al. Mitochondrial DNA al- teration in esophageal cancer[J]. Int J Cancer, 2001,92 (3) : 319-321.
  • 9Fan H,Wang C,Guo Z. Single nucleotide polymorphisms in the mitoehondrial displacement loop and age at onset of non-Hodgkin lymphoma[J]. Onco Targets Ther, 2013,6 : 1041-1045.
  • 10Bai Y, Guo Z, Xu J, et al. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome[J]. Mitochondrial DNA, 2015,26 (2) : 224- 226.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部